The Role Of Omega 3 Supplementation In Repeated Transient Ischemic Attack : A Case Report
Abstract
Introduction: According to a 2021 worldwide analysis, 1 in 4 adults will suffer a stroke in their lifetime. Risk factors include hypertension, diabetes mellitus, dyslipidemia, and atrial fibrillation. Lifestyle is a critical factor in stroke prevention. More importantly, dietary habits were shown to be the most relevant. To reduce the risk of ischemic stroke, nutritional approaches have historically focused on high-fiber diets with low in sodium, saturated fat, and cholesterol. It is well known that n-3 PUFAs reduce the risk of cardiovascular diseases. Case Report: A 65-years old woman present with headache and myalgia. She was grade I obese with a body weight of 69 kg. The patient has history of transient ischemic attack (TIA) twice within a year. There is a history of type 1 diabetes mellitus thus taking insulin for a year and hypertension for 2 years. On examination, the blood pressure was 170/90 mmHg. Both of her foot were swollen. Laboratory test results were normal. History of medication includes Amlodipine, Candesartan, Furosemide, dan Glargine. Omega 3 supplementation was planned to reduce inflammation and risk of future episodes of stroke. Conclusion: Omega-3 PUFA have various pharmacological activities, such as anti-inflammatory, anti-thrombosis, anti-atherosclerosis, reduce blood lipid levels and significantly improve endothelial dysfunction. Omega-3 is also beneficial in obesity and diabetics, which are risk factors of stroke or TIA.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.